antolin_aa Profile Banner
Albert A. Antolin (he/him) Profile
Albert A. Antolin (he/him)

@antolin_aa

Followers
630
Following
4K
Media
94
Statuses
1K

PI & @SaludISCIII Miguel Servet Fellow @ProcureICO @idibell_cat @ICO_oncologia | Harnessing Systems Chemical Biology to better cancer treatment🏳️‍🌈👨‍👨‍👧✊🏾

Barcelona, Spain
Joined October 2013
Don't wanna be here? Send us removal request.
@antolin_aa
Albert A. Antolin (he/him)
1 year
Thrilled to share the 1st paper from my lab @chemicalbiology Rucaparib and its major metabolite have different activity that becomes synergistic in prostate cancer lines & active in a #Parkinson model @ICR_London @ProcureICO @ICO_oncologia @idibell_cat A🧵.
cell.com
Hu et al. comprehensively characterized the kinome profile of the major metabolite of rucaparib, M324. The study uncovers distinct kinase landscapes between rucaparib and M324 that translate into a...
7
4
34
@antolin_aa
Albert A. Antolin (he/him)
15 days
RT @REPO4EU: #RExPO25 Conference abstract: 'Leveraging cancer drug metabolites for precision drug repurposing' ➡ .
0
3
0
@antolin_aa
Albert A. Antolin (he/him)
2 months
RT @ASEICAnews: 20th #ASEICACongress.8-10OCT.Bilbao(Spain).5⃣0⃣0⃣Scientists.5⃣0⃣Speakers.Meet the Expert and6⃣Sessions.👉Late Abstract Submi….
0
11
0
@antolin_aa
Albert A. Antolin (he/him)
4 months
RT @idibell_cat: 🌕L'investigador #IDIBELL Albert Antolin @antolin_aa va participar al programa Planeta Catalluna de @RadioGava, amb Maripaz….
0
2
0
@antolin_aa
Albert A. Antolin (he/him)
5 months
Un plaer i un honor participar amb l’Associacio Viladecans Contra el Cancer en aquest projecte!.
@idibell_cat
IDIBELL
6 months
🚀Tret de sortida del projecte 2025 de l’Ass. Viladecans Contra el Càncer: el Dr. Albert Antolin (@antolin_aa) explica com fem recerca de nous fàrmacs amb eines d’Intel•ligència Artificial #IA 💻, i com volem aplicar aquesta estratègia a la #immunoteràpia del càncer colorectal.
Tweet media one
Tweet media two
Tweet media three
0
0
7
@antolin_aa
Albert A. Antolin (he/him)
6 months
RT @thesgconline: We are uniting experts in ML, computational chemistry, and drug discovery to get hands-on experience with AIRCHECK. Co-de….
0
3
0
@antolin_aa
Albert A. Antolin (he/him)
7 months
#MAINFRAME is launching! This international, #OpenScience Network brings #MachineLearning & #compchem scientists together to create open-source algorithms & benchmarks for tackling real-world challenges in #DrugDiscovery. Join us:
0
3
9
@antolin_aa
Albert A. Antolin (he/him)
7 months
RT @JCIM_JCTC: 📢 Check the new Volume 64 Issue 23 of #JCIM
Tweet media one
0
3
0
@antolin_aa
Albert A. Antolin (he/him)
8 months
Join us!!.
@thesgconline
Structural Genomics Consortium (SGC)
8 months
We just launched #MAINFRAME! This international, #OpenScience Network brings #MachineLearning & #compchem scientists together to create open-source algorithms & benchmarks for tackling real-world challenges in #DrugDiscovery. Join us:
Tweet media one
0
1
5
@antolin_aa
Albert A. Antolin (he/him)
8 months
RT @ChEMBL: The ChEMBL-og: Here's a nice Christmas gift - ChEMBL 35 is out!
0
4
0
@antolin_aa
Albert A. Antolin (he/him)
8 months
RT @chem4biology: 8 billion. It's just a number. Today, our 3D tranche browser shows 8 billion* purchasable molecules in biologically relev….
0
5
0
@antolin_aa
Albert A. Antolin (he/him)
8 months
RT @thesgconline: A 2024 update on @Chemical_probes highlights a significant expansion in the number of chemical probes and human protein t….
Tweet card summary image
academic.oup.com
Abstract. The Chemical Probes Portal (www.chemicalprobes.org) is a free, public resource, based on expert-reviews, that supports the assessment, selection 
0
3
0
@antolin_aa
Albert A. Antolin (he/him)
8 months
RT @thesgconline: A fully open framework for DEL-ML hit discovery. We replace explicit DEL compound structures with ML-ready chemical finge….
0
2
0
@antolin_aa
Albert A. Antolin (he/him)
8 months
RT @AdeSaurin: Our latest work shows a reported #kinase.inhibitor causes cytotoxicity by directly inhibiting MTs. We need more clarity on h….
Tweet card summary image
aacrjournals.org
Abstract. Elraglusib (9-ING-41) is an ATP-competitive inhibitor of glycogen synthase kinase-3 (GSK3) with preclinical studies demonstrating broad activity against many tumor types. Promising early-...
0
5
0
@antolin_aa
Albert A. Antolin (he/him)
8 months
Happy to have contributed! Great increase in numbers and functionality, have a look!.
@Chemical_probes
Chemical Probes Portal
8 months
🚨 New publication alert! 🚨.Our latest update on the Chemical Probes Portal is live! 🎉. 📜 Read the paper: 🔍 Learn about our expanded content + improved functionality in the 2024 Nucleic Acids Research Database Issue. #ChemicalProbes #BiomedicalResearch
Tweet media one
1
1
5
@antolin_aa
Albert A. Antolin (he/him)
8 months
RT @NatRevDrugDisc: The FDA has approved revumenib, the first menin inhibitor for relasped or refractory acute leukaemia with a KMT2A trans….
0
13
0
@antolin_aa
Albert A. Antolin (he/him)
8 months
RT @aledmedwards: This WD paper reports machine learning applied to DNA-encoded library screening datasets at scale. Bottom line it works….
0
2
0
@antolin_aa
Albert A. Antolin (he/him)
9 months
RT @FerranFeceCruz: Sunny day, coffee ready: a perfect morning to apply for jobs in Europe! #Barcelona #Help.
0
1
0
@antolin_aa
Albert A. Antolin (he/him)
9 months
RT @mattschap: All participants to CACHE challenges are invited to join the overview paper. CACHE#1 learnings: .-….
0
6
0